Project Grant HT94252410890
Award Date
9/1/24
Completion Date
8/31/27
Dollars Obligated
$1.1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New Zealand
Similar Awards
The University of Auckland in New Zealand was awarded a $534,258 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research applying enhanced electroceutical treatments and identifying electrical biomarkers for spinal cord injury from September 1, 2023 through August 31, 2026. As part of its mission to transform military and public health through innovative medical research solutions, the Defense Health...
The U.S. Department of the Army Medical Command awarded a $494,774 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to Aarhus Universitet, a Danish educational institution, to develop nonmotor biomarkers to diagnose Parkinson's disease subtypes early on. The award, which runs from December 15, 2024 to December 14, 2026, will support advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader...
This $2,000,000 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research on the interrelationship between the PINK1-PRKN pathway disruption and tauopathy in the pathophysiology of cognitive impairment in Parkinson's disease. The award, with a performance period from June 1, 2025 to May 31, 2028, was granted to the Board of Regents of the University of Nebraska, through its University of Nebraska Medical...
This $1,199,967 Project Grant awarded on September 1, 2023 by the Defense Health Agency supports research under the Military Medical Research and Development (CFDA 12.420) program. The primary award recipient, the University of Vermont & State Agricultural College, will investigate "Cognitive Functions Impairment as a Novel Paradigm for Delineating Cognitive Dysfunction in Parkinson's Disease". Two sub-awards were made to Case Western Reserve University and the Portland VA Research...
This federal Project Grant award of $1,021,409.00 from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program will support research at the University of Illinois to investigate the underlying neurobiology of non-motor symptoms in Parkinson's disease. The research aims to elucidate the role of serotonin system plasticity in the development of these disabling non-motor complications, which can include cognitive, psychiatric, and...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $968,717 to the University of Melbourne in Australia to conduct research aimed at solving a major complication of Parkinson's disease - debilitating constipation - through novel pharmacology. The research project will run from April 2025 to April 2028, targeting innovative solutions to address this significant health challenge for military service members and...
The Department of the Army Medical Command has awarded a $1,173,445 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Council of the Queensland Institute of Medical Research, doing business as QIMR Berghofer Medical Research Institute, in Australia. The grant, awarded on September 1, 2024, will fund a research project titled "The Nose Knows: Harnessing Human Olfactory Cells to Identify Biomarkers of Nonmotor Changes in Parkinson's...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,493,233 to The Trustees of Columbia University in the City of New York to fund research on gene therapy in a nonhuman primate model of cognitive defects in Parkinson's disease. The award commenced on November 15, 2024 and is set to be completed by November 14, 2027. The university's Health Sciences Division will leverage its...
This federal Project Grant award of $673,448.00, provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research focused on transforming healthcare for military service members and the broader public. The award was granted to The Research Foundation For The State University Of New York (RF SUNY) to conduct research on the "MALADAPTIVE 5-HT RAPHE-CORTICOLIMBIC PLASTICITY UNDERLYING THE...
The Department of the Army Medical Command awarded a $1,440,764 Project Grant to The Trustees of Columbia University in New York, New York to support research titled "NOVEL EXPOSOMICS AND EXTRACELLULAR VESICLE BIOMARKERS TO UNRAVEL GENE - ENVIRONMENT INTERACTIONS AND MECHANISMS OF NEURODEGENERATION IN PARKINSON'S DISEASE." The grant is funded under the Military Medical Research and Development program (CFDA 12.420) and aims to transform military and public health care through...